PCN31 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment for Patients with HER2-Positive EARLY Breast Cancer: Update Results after National Drug Reimbursement LIST Adjustment in China

Authors :: C.F. Hao
Y.S. Wang
Hongchao Li
Q. Yang
Q.J. Chen
Jiming Zhang
J.J. Li
C. Liu
X. Guan
Hanmei Xu
A.X. Ma
Source :: Value in Health Regional Issues. 22:S10
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
Chemotherapy
business.industry
Health Policy
Drug reimbursement
medicine.medical_treatment
Economics, Econometrics and Finance (miscellaneous)
Cost-effectiveness analysis
Trastuzumab
Internal medicine
medicine
Pertuzumab
business
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Adjuvant
Early breast cancer
medicine.drug

Full Text Access

Tools